QA Testing

California
download/print PDF version
reload without photo
PharmLabs San Diego Certificate of Analysis
Sample B
Delta9 THC 76.88% THCa ND Total THC (THCa * 0.877 + THC) 76.88%
Logo_coa
Sample ID  SD190122-002 (33454) Matrix   Concentrate
Tested for  Wiesehan Alyssa
Sampled   - Received   Jan 22, 2019 Reported   Jan 23, 2019
Analyses executed   CAN

CAN - Cannabinoids

Analyzed Jan 23, 2019  |  Instrument HPLC-VWD  | Method SOP-001
The expanded Uncertainty of the Cannabinoids analysis is approximately ± 7.81% at the 95% Confidence Level
Analyte   LOD
mg/g
LOQ
mg/g
Result
%
Result
mg/g
Cannabidiolic Acid (CBDA)   0.033 0.16 ND ND
Cannabigerol (CBG)   0.048 0.16 ND ND
Cannabidiol (CBD)   0.069 0.229 ND ND
Cannabinol (CBN)   0.047 0.16 1.75 17.50
Tetrahydrocannabinol (Δ9-THC)   0.092 0.307 76.88 768.80
Δ8-tetrahydrocannabinol (Δ8-THC)   0.044 0.16 NT NT
(6aR,9S)-Δ10-Tetrahydrocannabinol ((6aR,9S)-Δ10)   0.015 0.8 NT NT
(6aR,9R)-Δ10-Tetrahydrocannabinol ((6aR,9R)-Δ10)   0.007 0.8 NT NT
Tetrahydrocannabinolic Acid (THCA)   0.117 0.389 ND ND
Total THC ( THCa * 0.877 + Δ9THC )       76.88 768.80
Total CBD ( CBDa * 0.877 + CBD )       ND ND
Total Cannabinoids Analyzed       78.63 786.30